Consistent with the inhibitory role of CDK8 on de novo lipogenesis, nuclear SREBP-1c proteins and lipogenic enzymes are accumulated in NAFLD models. Here, CDK8 is linked to metabolic dysfunction-associated steatotic liver disease.